Uday Baldota serves as CEO of Taro Pharmaceuticals*. He has over 20 years of management experience, a significant portion of which has been with Sun.
In addition to holding various leadership positions, Uday has been an integral part of Sun’s worldwide growth – including leading several important acquisitions and integrations, most recently that of Ranbaxy.
Uday has both an MBA from the Indian Institute of Management, Ahmedabad and a Chemical Engineering degree from the Indian Institute of Technology, Delhi.
*a subsidiary of Sun Pharmaceutical Industries, Inc.